Literature DB >> 9776530

Neurodevelopmental outcome after prenatal exposure to opiates.

R Bunikowski1, I Grimmer, A Heiser, B Metze, A Schäfer, M Obladen.   

Abstract

UNLABELLED: To study the developmental effects of prenatal exposure to opiates, a prospective follow up study of 34 drug-exposed (opiates and nicotine) and 42 reference infants (nicotine exposure only) was conducted from January 1992 to September 1995. At the time of delivery, 12 of 34 mothers used opiates without medical control. Twenty-two mothers participated in a methadone maintenance programme. At 1 year, the average Griffiths Developmental Quotient (DQ) was lower in the drug-exposed group (mean: 100.5 vs. references 107.9; P < 0.001). This difference was mainly due to lower subscales "locomotor" (mean 100.8 vs. 111.4; P < 0.05) and "intellectual performance" (mean 100.8 vs. 108.5; P < 0.05) in the drug-exposed group. Severe developmental retardation mean DQ (-2 SD) was diagnosed in 2 drug-exposed infants. Mild developmental retardation (mean DQ: 1 SD- > 2 SD) was found in 7 drug-exposed and in 3 reference infants (P < 0.05). Neurological abnormalities were found more frequently in the drug-exposed group (11 vs. 3 infants; P < 0.01). Among the opiate-exposed infants, the subscales "hearing and speech" and "intellectual performance" were lower in the uncontrolled drug-using than in the methadone group. The 17 fostered infants showed no difference in developmental outcome compared with the 10 infants living with their biological parents (mean DQ: 100.0 versus 101.3).
CONCLUSIONS: At 1 year infants prenatally exposed to opiates are at risk for mild psychomotor developmental impairment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9776530     DOI: 10.1007/s004310050923

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  27 in total

1.  Prenatally buprenorphine-exposed children: health to 3 years of age.

Authors:  Kaisa Kivistö; Sarimari Tupola; Satu Kivitie-Kallio
Journal:  Eur J Pediatr       Date:  2015-05-24       Impact factor: 3.183

2.  Neonatal opioid withdrawal and antenatal opioid prescribing.

Authors:  Suzanne D Turner; Tara Gomes; Ximena Camacho; Zhan Yao; Astrid Guttmann; Muhammad M Mamdani; David N Juurlink; Irfan A Dhalla
Journal:  CMAJ Open       Date:  2015-01-13

Review 3.  Developmental consequences of fetal exposure to drugs: what we know and what we still must learn.

Authors:  Emily J Ross; Devon L Graham; Kelli M Money; Gregg D Stanwood
Journal:  Neuropsychopharmacology       Date:  2014-06-18       Impact factor: 7.853

4.  Novel biomarkers to assess in utero effects of maternal opioid use: First steps toward understanding short- and long-term neurodevelopmental sequelae.

Authors:  Laura Goetzl; Tara Thompson-Felix; Nune Darbinian; Nana Merabova; Salim Merali; Carmen Merali; Kathryne Sanserino; Tamara Tatevosian; Bruno Fant; Mathieu E Wimmer
Journal:  Genes Brain Behav       Date:  2019-06-11       Impact factor: 3.449

Review 5.  Developmental opioid exposures: Neurobiological underpinnings, behavioral impacts, and policy implications.

Authors:  Samantha S Goldfarb; Gregg D Stanwood; Heather A Flynn; Devon L Graham
Journal:  Exp Biol Med (Maywood)       Date:  2019-10-20

6.  Hospital Variation in Child Protection Reports of Substance Exposed Infants.

Authors:  Rebecca Rebbe; Joseph A Mienko; Emily Brown; Ali Rowhani-Rahbar
Journal:  J Pediatr       Date:  2019-02-13       Impact factor: 4.406

7.  Preadolescent behavior problems after prenatal cocaine exposure: Relationship between teacher and caretaker ratings (Maternal Lifestyle Study).

Authors:  Henrietta S Bada; Carla M Bann; Charles R Bauer; Seetha Shankaran; Barry Lester; Linda LaGasse; Jane Hammond; Toni Whitaker; Abhik Das; Sylvia Tan; Rosemary Higgins
Journal:  Neurotoxicol Teratol       Date:  2010-06-30       Impact factor: 3.763

8.  Opioids intrinsically inhibit the genesis of mouse cerebellar granule neuron precursors in vitro: differential impact of mu and delta receptor activation on proliferation and neurite elongation.

Authors:  K F Hauser; A A Houdi; C S Turbek; R P Elde; W Maxson
Journal:  Eur J Neurosci       Date:  2000-04       Impact factor: 3.386

9.  Skin conductance in neonates suffering from abstinence syndrome and unexposed newborns.

Authors:  Nicola Elisabeth Schubach; Katrin Mehler; Bernhard Roth; Eckhard Korsch; Rainhard Laux; Dominique Singer; Axel von der Wense; András Treszl; Christoph Hünseler
Journal:  Eur J Pediatr       Date:  2016-03-30       Impact factor: 3.183

10.  Sensitive, stimulating caregiving predicts cognitive and behavioral resilience in neurodevelopmentally at-risk infants.

Authors:  Sara R Jaffee
Journal:  Dev Psychopathol       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.